1. Home
  2. TAYD vs CRBU Comparison

TAYD vs CRBU Comparison

Compare TAYD & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$61.35

Market Cap

165.2M

Sector

Industrials

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.28

Market Cap

145.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
CRBU
Founded
1955
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.2M
145.8M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TAYD
CRBU
Price
$61.35
$1.28
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$70.00
$10.75
AVG Volume (30 Days)
35.7K
946.0K
Earning Date
03-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
2.62
N/A
Revenue
$41,649,673.00
N/A
Revenue This Year
$0.25
$1.63
Revenue Next Year
$19.78
$10.93
P/E Ratio
$23.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$40.50
$1.38
52 Week High
$90.37
$3.53

Technical Indicators

Market Signals
Indicator
TAYD
CRBU
Relative Strength Index (RSI) 58.75 33.21
Support Level $57.54 N/A
Resistance Level $62.42 $1.72
Average True Range (ATR) 1.95 0.08
MACD 0.11 -0.02
Stochastic Oscillator 71.10 0.00

Price Performance

Historical Comparison
TAYD
CRBU

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: